search
Front > News

Micromedic product diagnoses cervical cancer

12 Oct, 2014 18:27
שלח תגובה במיילGali Weinreb

Micromedic's parent company predicts significant sales of the product in China and India.

Micromedic Technologies Ltd. (TASE:MCTC), the cancer diagnosis technology unit in Bio-Light Israeli Life Sciences Investments Ltd. (TASE:BOLT; Bulletin Board: BLGTY), which owns 31% of Micromedic, has announced that a trial of its product for detecting cervical cancer at the Beijing military hospital showed that the product marks cancer cells, thereby rendering the diagnostic process more effective.

At the same time, Micromedic said that its current distributor in China would be unable to handle the anticipated sales volume. The company is therefore considering other possibilities for distribution in China. China and India are the main markets for Micromedic's test, because it is the only such test already in the commercial stage.

Several months ago, Bio-Light CEO Suzana Nahum-Zilberberg said that the company expected to sell "significant" quantities of its product over the coming year, but this will probably not be through the current distributor.

Bio-Light trades at a NIS 96 million market cap, and Micromedic at a NIS 10.7 million market cap. Bio-Light itself was recently mentioned in a study published by Concorde on the TearLab company, which is developing a product in competition with one of Bio-Light's ophthalmology products for diagnosis of dry eye syndrome. TearLab now trades at a $111.5 million market cap on this basis of this product alone. The analyst following TearLab met with Bio-Light, and wrote, "Bio-Light will be either Tear-Lab's competitor or its next acquisition. We are favorably impressed by Bio-Light."

Published by Globes [online], Israel business news - www.globes-online.com - on October 12, 2014

© Copyright of Globes Publisher Itonut (1983) Ltd. 2014

Arkia aircraft credit: Arkia Arkia to introduce business class on New York flights

For the first time in its history Arkia will operate business class with round-trip Tel Aviv New York tickets starting from $3,500.

Knesset passes 2025 budget credit: Noam Moskovitz Knesset Spokesperson Knesset approves 2025 state budget

The NIS 620 billion budget has ballooned by NIS 100 billion and will rely on a fiscal deficit of 4.9% of GDP.

Tel Aviv Stock Exchange credit: PR Volumes peak on Tel Aviv Stock Exchange

Greater optimism in Israel and a shift away from US markets have brought trading volumes in Tel Aviv to a historical high, but will the trend be sustained?

Volkswagen credit: PR VW announces huge collaboration with Mobileye

A new advanced driving assistance system will be installed in millions of cars annually.

Navina founders Ronen Lavi and Shay Perera credit: Eyal Izhar Israeli clinical AI co Navina raises $55m

Navina equips clinicians and care teams with real-time, data-driven insights that improve the quality of care and financial outcomes.

Yoni Assia credit: eToro PR Trading platform eToro set for IPO

The company has filed a prospectus with the SEC, showing that its revenue tripled in 2024, with 96% deriving from crypto trading.

Minister of Finance Bezalel Smotrich and Minister of Transport Miri Regev credit: Marc Israel Sellem, The Jerusalem Post Deal: Gush Dan congestion charge for Kiryat Shemona railway

Miri Regev is close to final agreement with the Ministry of Finance on funding for her pet project in return for removal of her objection to the congestion charge.

Nakash brothers credit: Aviv Hoffi Nakash brothers set to dissolve Israel partnership

Avi Nakash has fallen out with Joe and Rafi Nakash over his claims that former CEO Avi Hormaro stole rights in the Group's companies, which include Arkia, the Orchid hotel chain and Ampa.

Air Haifa credit: ATR Paphos ban for Israeli airlines continues to May

Air Haifa has postponed the launch of its Haifa-Paphos route until May 1, signaling that the security ban on Israeli airlines using the Cypriot airport will continue in April.

ONE ZERO CEO Eyal Gafni credit: Cadya Levy One Zero CEO: Outdated fees can be avoided with simple awareness

Eyal Gafni told the Globes "Going Long on Israel" Conference that with higher awareness the public can stop keeping their money in current accounts with zero returns.

Shekels credit: Shutterstock Vladerina32 Shekel rebounds on volatile forex market

Without a further trigger, such as an escalation on the security front or a further deterioration in political stability, there is no expectation in the market for foreign exchange turmoil.

Ishay Davidi credit: Cadya Levy FIMI CEO: Foreign investors flocking back to Israel

Ishay Davidi told the Globes "Going Long on Israel" Conference that investors who pulled out of Israel after October 7 have begun returning in large numbers.

Yali Rothenberg credit: Cadya Levy Accountant General: No prospect of rating upgrade

Ministry of Finance Accountant General Yali Rothenberg sees 2025 as a stabilizing year for Israel's debt:GDP ratio.

Wix Credit: PR Wix employees gain $102m on options

The intrinsic value of options exercised by Wix employees in 2024 rose to $102 million from $19.5 million in 2023.

Tel Aviv Stock Exchange credit: Shutterstock Tel Aviv stocks: Rebound or long slide?

Statistics show a two-thirds chance of high returns after a steep one-day fall. Yields on Israel government bonds are rising sharply.

Attorney General Gali Baharav-Miara credit: Eyal Izhar AG slams gov't for seeking to be above the law

Attorney General Gali Baharav-Miara did not attend the cabinet meeting, which unanimously passed a no confidence vote in her.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018